PROC (Procaps Group) Yalpi foyda bo'yicha rentabellik

PROC (Procaps Group Corp) - kompaniyaning tovar belgisi

Procaps Group S.A. kompaniyasi birlashmalardan vaqtincha voz kechgan holda, organik o'sish va auditga e'tibor qaratmoqda. Biznes samaradorligi birlik xarajatlarini kamaytirish uchun CDMO quvvatlaridan foydalanishni maksimallashtirishga bog'liq. Polimer narxlari va kapsulalarga bo'lgan talabga bog'liqlik joriy yalpi foyda marjasini belgilaydi, bunda 0.00 bugungi metrika qiymatini ifodalab, kompaniyaning ishlab chiqarish daromadliligini vizuallashtiradi.

Procaps Group Corp (PROC) Yalpi rentabellik: 04.07.2022 - 16.02.2025 davri uchun

Procaps Group S.A. (PROC) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- biznesning bozor baholash ko'rsatkichlari:
Fundamental baholash:PROC (Procaps Group)
Procaps Group Corp seriyali mahsuloti

Yalpi foyda marjasi tushum va sotilgan tovarlarning bevosita xarajatlari orasidagi farqning umumiy savdoga nisbati sifatida hisoblanadi. Ushbu ko'rsatkich ishlab chiqarish jarayonlarining samaradorligini va operatsion xarajatlar chegirilmasdan oldin biznesning foyda ulushini saqlab qolish qobiliyatini belgilaydi. Procaps Group S.A. (PROC) ning Lotin Amerikasi aktivlarining qarz yuklamasini hisobga olgan holda, yalpi foyda marjasi tendentsiyasi ishlab chiqarish rentabelligiga bo'lgan bosimni monitoring qilish uchun muhim vositaga aylanadi.

Asosiy raqobatchilar

Yalpi foyda marjasi Haleon PLC (HLN)|Yalpi foyda bo'yicha rentabellik KVUE|Yalpi foyda marjasi Verona Pharma Inc. VRNA|Yalpi marja MENS|Ligand Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik Amneal AMRX|Sotuvning yalpi marjinal rentabelligi Perrigo Company PLC|Alvotech Biopharmaceuticals - Yalpi marja|Yalpi foyda bo'yicha sotuv rentabelligi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Yalpi rentabellik|anipharmaceuticals.com - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik MNKD|AMPH: Yalpi foyda normasi|Yalpi rentabellik pacira.com (PCRX)|Yalpi marja ARS Pharma (SPRY)|Theravance Biopharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Tectonic Therapeutic|TNXP: Yalpi marja|SXT China (SXTC) - Yalpi marja|Yalpi rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Invizyne (EXOZ)|ORMP - Yalpi foyda marjasi|Yalpi marja ENTX (Entera Bio)|Sotuvning yalpi marjinal rentabelligi MindWalk Therapeutics|ABVC: Yalpi foyda bo'yicha rentabellik|CPIX - Yalpi marja|QNTM (Quantum BioPharma) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha marjinallik FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Yalpi marja|Yalpi marja ranitherapeutics.com|Yalpi rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Sotuvning yalpi rentabelligi|lexariabioscience.com - Yalpi foyda bo'yicha rentabellik|Yalpi marja Pulmatrix Inc PULM|Pheton Holdings - Yalpi marja|Yalpi foyda bo'yicha marjinallik APM|Lyra Therapeutics, Inc. (LYRA) - Yalpi rentabellik|Yalpi foyda marjasi Impact BioMedical, Inc. (IBO)|Yalpi rentabellik TNF Pharma|YCBD: Yalpi foyda normasi|Yalpi marja PRFX|CYTO - Yalpi foyda marjasi|Yalpi rentabellik Lipella LIPO|Yalpi foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik PTPI|QLI: Yalpi marja|Yalpi foyda marjasi ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Yalpi marja